Search

This article discusses the findings of three studies related to neonatal neuroprotection. The first study explores the potential use of haptoglobin as a treatment for cerebral intraventricular hemorrhage in preterm infants. The second study examines the impact of anakinra on immune function in infants with neonatal encephalopathy. The third study explores the therapeutic potential of human mesenchymal stem cells in encephalopathy of prematurity. These studies provide insights into potential treatments for neurodevelopmental impairments in preterm infants. Another study evaluates the impact of telemedicine consults on the time it takes to assess neonatal encephalopathy in a rural state, finding that the program significantly reduced assessment time and improved collaboration and communication. A study on infants with hypoxic-ischemic encephalopathy investigates the levels of immune regulatory cells and suggests their potential use as an adjuvant strategy to reduce inflammation. Lastly, a study compares the use of morphine in neonates undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy using two different cooling devices, finding no significant difference in morphine use between the groups. These studies highlight the need for further research and interventions to improve outcomes for infants with neonatal encephalopathy and hypoxic-ischemic encephalopathy. [Extracted from the article]